Attorney General Sam Olens said it concludes a probe into whether the pharmaceutical giant engaged in illegal off-label marketing schemes to promote the sales of its urology drug Detrol.
Detrol was approved by the Food and Drug Administration in1998 for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. The settlement resolves allegations that Pfizer's promotional activities were designed to increase Detrol for other uses for which it was not approved.
The total value of the national civil settlement is $14 million.
The probe was a joint investigation by the United States Attorney's Office for the District of Massachusetts and the U.S. Department of Justice.